Glen David, MD
Interventional Pain Medicine · Seattle, WANPI 1639285182
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 36.8% of the total. Reporting peaked in 2023 at $4,237 and has fallen 81.0% since, to $807 in 2025.
Across 169 payments — averaging $82.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$4K
- Merit Medical Systems Inc$3K
- Stryker$943
- Foundation Fusion Solutions, LLC$365
- Biotronik NRO, Inc.$212
- plus $543 from 7 others
Across 2 payments — averaging $2410.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$4K
- Medtronic$820
What the payments were for
- Consulting fees$3,20023%
- Speaking & faculty fees$4,25531%
- Travel & lodging$1,0227%
- Food & beverage$5,47239%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 29 | $5,139 |
| Boston Scientific | 102 | $3,524 |
| Merit Medical Systems Inc | 3 | $3,223 |
| Stryker | 12 | $943 |
| Foundation Fusion Solutions, LLC | 2 | $365 |
| Biotronik NRO, Inc. | 2 | $212 |
| Painteq LLC | 3 | $152 |
| Abbott | 8 | $130 |
| Spinal Simplicity, LLC | 1 | $124 |
| Saluda Medical Americas, Inc. | 4 | $45 |
| Cala Health, Inc. | 1 | $37 |
| Si-bone, Inc. | 1 | $32 |
| Relievant Medsystems, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Power Curve II$3,200
- StabiliT$3,200
- Arcadia$3,200
- KYPHON EXPRESS II KYPHOPAK TRAY$2,417
- KYPHON Balloon Kyphoplasty$1,980
- GENERAL PAIN MANAGEMENT$943
- Intracept$541
- IVAS$276
- INTELLIS ADAPTIVESTIM$160
- IVS - MULTIGEN RF$150
- IVS - IVAS$150
- SPINEJACK$133
- BIOTRONIK$132
- SPECTRA WAVEWRITER$124
- PAINTEQ$124
- HA MINUTEMAN G3-R$124
- WaveWriter Alpha Prime 16$104
How this compares
$13,948 in reported general payments places this provider in the 85th percentile of 30 interventional pain medicine providers in Washington.
See all interventional pain medicine providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 72 | $711 |
| Methylprednisolone | 20 | $166 |
| Methocarbamol | 11 | $149 |
| Mupirocin | 13 | $104 |
| Cephalexin | 14 | $45 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Seattle
- Diyan RazaSeattle$12K
- Bao DinhSeattle$4K
- Ray BakerKirkland$1.2M
- Daniel NelsonKirkland$29K
- Kyong KimLakewood$23K
- Hyun HongOlympia$16K
- Kiang Yien CheungTacoma$12K
- Kathy WangPuyallup$11K
- Allen ShohamRichland$8K
- Kashif SaeedTacoma$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.